Global Biochips Market is Anticipated to Grow at a CAGR of 8.6% during Forecast Period


Posted June 6, 2017 by snehakumar

The global biochips market is estimated to reach $9 billion by 2024 from $4 billion in 2016; growing at a CAGR of 8.6% from 2016 to 2024.

 
The global biochips market is estimated to reach $9 billion by 2024 from $4 billion in 2016; growing at a CAGR of 8.6% from 2016 to 2024. The biochips market is majorly driven by the following driving factors such as increasing demand for customized medicines, growing applications in drug discovery and rising occurrence of HIV and cancer. However, high cost of devices and lack of regulations might hinder the growth of the market. Furthermore, growing applications of biochips for the point-of-care diagnostics and development of advanced devices for cattle disease detection and drug lead identification would provide growth opportunities for the market.
Browse Complete Report @ https://www.variantmarketresearch.com/report-categories/semiconductor-electronics/biochips-market
Type, application and geography are the key segments of the global biochips market. Type segment has been segmented into DNA chips, microfluidic devices and protein chips. DNA chips was the leading sub segment with highest market share in 2016 and protein chips held the second largest market. Additionally, Application segment includes in vitro diagnostics (IVD), proteomics, drug discovery & development and genomics.
Get Sample Report @ http://bit.ly/2rZ03T3
The global biochips market by geography is bifurcated into North America, Europe, Asia-Pacific and RoW. North America held the highest market share of 32.2% in 2016, driven by growing advancements in biochip technology and rising demand for personalized medicine. Moreover, Asia-Pacific region is anticipated to grow at the fastest CAGR over the forecast period, owning to rising awareness and growing investments on the R&D for advanced diagnostic techniques.
Various strategies have been adopted by the market players to boost their geographical presence and product portfolio. The major players in the biochips market include Roche Diagnostics, Affymetrix Inc., Illumina Inc., Abbott Laboratories, GE Healthcare, Fluidigm Corporation, Agilent Technologies Inc., Bio-Rad Laboratories, Cepheid Inc., and Sigma-Aldrich Corporation, among others.
For information, contact:
VARIANT MARKET RESEARCH LLP
Web: https://www.variantmarketresearch.com/
USA Office:
649 Mission St.,
5th Floor, San Francisco,
CA 94105, United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: [email protected]
India Office (Corporate Headquarter):
Office No. FL No.7, Prakash Developers,
Survey no 34/A5, Wadgaon Sheri,
Nagar Road, Pune – 411014
Tel: +91 20 65337795
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By sneha
Country United States
Categories Business
Last Updated June 6, 2017